Recent News
On April 2, 2026 the Board declared a regular quarterly dividend of $0.16 per share payable June 15, 2026 to holders of record May 29, 2026. The company announced a CEO transition effective on or about April 13, 2026 and related board resignation disclosures. On May 5, 2026 the company scheduled release of fourth-quarter and full fiscal year results for May 27, 2026. The company previously published third-quarter fiscal 2026 results on February 3, 2026.
Technical Analysis
Trend Strength (ADX/DI+/DI-): ADX at 18.76 indicates no dominant trend; DI+ at 25.62 (decreasing) reads as bearish pressure while DI- shows a peak & reversal, which reads as bullish — the directional indicators therefore conflict and point to a range-bound market unless ADX rises above 20.
MACD: MACD shows a dip & reversal, indicating building bullish momentum, but MACD (2.99) remains marginally below the signal line (3.00); a confirmed cross above the signal line would strengthen near-term upside conviction.
MRO: MRO at -3.35 sits below zero, indicating the market price trades below the target and implies price upside potential; the small absolute value signals limited immediate pressure toward a large move.
RSI: RSI at 58.13 with a dip & reversal indicates regained buyer interest without an overbought extreme, consistent with the case for modest continuation rather than a sharp reversal.
Price vs. Moving Averages & Bands: Last close $102.99 sits above the 20-day average ($100.25), 50-day ($91.29) and 200-day ($79.54); the 12-day EMA shows a dip & reversal. Price sits just under the 1x Bollinger upper band ($103.25), suggesting near-term upside exists but faces band resistance.
Support, Volume, Volatility: SuperTrend lower support appears near $94.62. Volume (172,978) runs above the 10-, 50-, and 200-day averages, showing elevated participation behind the move; 42-day and 52-week volatility remain moderate at ~4%.
Fundamental Analysis
Profitability: Gross margin stands at 64.18%, above the industry peer mean of 61.85%, supporting product-level pricing power. Operating margin registers 12.25%, below the industry peer mean of 21.70%; EBIT margin sits at 11.72%, below the industry peer mean of 20.56%, indicating room to compress operating inefficiencies relative to peers. The company reported an earnings-per-share result of $1.76 versus an estimate of $1.47, an EPS surprise ratio of 19.73%, reflecting recent operational upside.
Growth: Reported total revenue equals $65,126,000 with reported revenue growth of 7.23% on the latest basis and year-over-year revenue change of -16.54%; quarter-over-quarter revenue movement shows a 2.60% change. Earnings growth registers 2.91% with a quarter-over-quarter gain of 22.80% and a year-over-year change of -3.20%, indicating mixed near-term momentum across periods.
Cash Flow & Liquidity: Operating cash flow reached $18,754,000 and free cash flow $18,022,000, producing a free cash flow yield of 4.07%, ahead of the industry peer mean of 0.97%. Cash and short-term investments total $28,975,000 and the cash conversion ratio equals 1.27. Current and quick ratios sit at 1.94 and 1.45 respectively, with the current ratio below the industry peer mean of 2.66, indicating reasonable but not excess short-term liquidity.
Leverage & Returns: Total debt equals $180,979,000 with net debt $137,152,000; debt-to-assets sits at 41.62%, above the industry peer mean of 28.18%. Interest coverage near 2.51 suggests serviceability but lower coverage versus the industry peer mean. Return on equity registers 1.94%, below the industry peer mean of 3.08%, while return on assets at 0.84% remains modest. These metrics point to conservative profitability on invested capital alongside higher leverage than peers.
Valuation: WMDST values the stock as under-valued. Market multiples show elevated P/E and P/S levels versus typical small-cap medtech ranges, reflecting thin share float dynamics and the recent earnings beat; the firm’s free cash flow yield and high gross margin form the core support for the under-valued determination.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-03 |
| NEXT REPORT DATE: | 2026-05-05 |
| CASH FLOW | Begin Period Cash Flow | $ 20.4 M |
| Operating Cash Flow | $ 18.8 M | |
| Capital Expenditures | $ -732.00 K | |
| Change In Working Capital | $ 4.5 M | |
| Dividends Paid | $ -884.00 K | |
| Cash Flow Delta | $ 8.6 M | |
| End Period Cash Flow | $ 29.0 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 65.1 M | |
| Forward Revenue | $ 33.4 M | |
| COSTS | ||
| Cost Of Revenue | $ 23.3 M | |
| Depreciation | $ 1.3 M | |
| Depreciation and Amortization | $ 5.7 M | |
| Research and Development | $ 5.0 M | |
| Total Operating Expenses | $ 57.2 M | |
| PROFITABILITY | ||
| Gross Profit | $ 41.8 M | |
| EBITDA | $ 13.3 M | |
| EBIT | $ 7.6 M | |
| Operating Income | $ 8.0 M | |
| Interest Income | — | |
| Interest Expense | $ 3.0 M | |
| Net Interest Income | $ -3.04 M | |
| Income Before Tax | $ 4.6 M | |
| Tax Provision | $ 966.0 K | |
| Tax Rate | 21.0 % | |
| Net Income | $ 3.6 M | |
| Net Income From Continuing Operations | $ 3.6 M | |
| EARNINGS | ||
| EPS Estimate | $ 1.47 | |
| EPS Actual | $ 1.76 | |
| EPS Difference | $ 0.29 | |
| EPS Surprise | 19.728 % | |
| Forward EPS | $ 1.35 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 434.8 M | |
| Intangible Assets | $ 278.9 M | |
| Net Tangible Assets | $ -92.26 M | |
| Total Current Assets | $ 105.6 M | |
| Cash and Short-Term Investments | $ 29.0 M | |
| Cash | $ 29.0 M | |
| Net Receivables | $ 40.2 M | |
| Inventory | $ 26.6 M | |
| Long-Term Investments | $ 17.2 M | |
| LIABILITIES | ||
| Accounts Payable | $ 5.3 M | |
| Short-Term Debt | $ 5.2 M | |
| Total Current Liabilities | $ 54.4 M | |
| Net Debt | $ 137.2 M | |
| Total Debt | $ 181.0 M | |
| Total Liabilities | $ 248.2 M | |
| EQUITY | ||
| Total Equity | $ 186.7 M | |
| Retained Earnings | $ -180.73 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 33.79 | |
| Shares Outstanding | 5.525 M | |
| Revenue Per-Share | $ 11.79 | |
| VALUATION | Market Capitalization | $ 442.5 M |
| Enterprise Value | $ 594.5 M | |
| Enterprise Multiple | 44.543 | |
| Enterprise Multiple QoQ | -17.325 % | |
| Enterprise Multiple YoY | -65.041 % | |
| Enterprise Multiple IPRWA | high: 158.913 mean: 80.513 median: 74.451 MLAB: 44.543 low: -144.328 |
|
| EV/R | 9.129 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 2.329 | |
| Asset To Liability | 1.752 | |
| Debt To Capital | 0.492 | |
| Debt To Assets | 0.416 | |
| Debt To Assets QoQ | -5.946 % | |
| Debt To Assets YoY | 80.294 % | |
| Debt To Assets IPRWA | high: 0.828 MLAB: 0.416 mean: 0.282 median: 0.262 low: 0.002 |
|
| Debt To Equity | 0.969 | |
| Debt To Equity QoQ | -9.15 % | |
| Debt To Equity YoY | 49.104 % | |
| Debt To Equity IPRWA | high: 3.261 MLAB: 0.969 mean: 0.564 median: 0.472 low: -1.334 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 2.37 | |
| Price To Book QoQ | 3.932 % | |
| Price To Book YoY | -48.189 % | |
| Price To Book IPRWA | high: 13.986 mean: 5.871 median: 5.854 MLAB: 2.37 low: -0.373 |
|
| Price To Earnings (P/E) | 45.508 | |
| Price To Earnings QoQ | 29.79 % | |
| Price To Earnings YoY | -109.054 % | |
| Price To Earnings IPRWA | high: 269.298 mean: 118.111 median: 101.834 MLAB: 45.508 low: -228.062 |
|
| PE/G Ratio | 0.156 | |
| Price To Sales (P/S) | 6.795 | |
| Price To Sales QoQ | 1.394 % | |
| Price To Sales YoY | -39.869 % | |
| Price To Sales IPRWA | high: 52.884 mean: 19.449 median: 19.3 MLAB: 6.795 low: -13.339 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 57.092 | |
| Forward PE/G | 0.196 | |
| Forward P/S | 13.252 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | 7.889 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.151 | |
| Asset Turnover Ratio QoQ | 7.344 % | |
| Asset Turnover Ratio YoY | 6.758 % | |
| Asset Turnover Ratio IPRWA | high: 0.512 MLAB: 0.151 median: 0.14 mean: 0.128 low: -0.209 |
|
| Receivables Turnover | 1.622 | |
| Receivables Turnover Ratio QoQ | 5.671 % | |
| Receivables Turnover Ratio YoY | 1.774 % | |
| Receivables Turnover Ratio IPRWA | high: 2.907 mean: 1.869 median: 1.837 MLAB: 1.622 low: 0.47 |
|
| Inventory Turnover | 0.859 | |
| Inventory Turnover Ratio QoQ | 2.52 % | |
| Inventory Turnover Ratio YoY | 7.69 % | |
| Inventory Turnover Ratio IPRWA | high: 2.05 MLAB: 0.859 mean: 0.705 median: 0.548 low: 0.16 |
|
| Days Sales Outstanding (DSO) | 56.273 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 141.954 | |
| Cash Conversion Cycle Days QoQ | -4.892 % | |
| Cash Conversion Cycle Days YoY | -8.238 % | |
| Cash Conversion Cycle Days IPRWA | high: 453.393 mean: 166.086 median: 165.533 MLAB: 141.954 low: -118.454 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 1.271 | |
| CapEx To Revenue | -0.011 | |
| CapEx To Depreciation | -0.576 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 347.7 M | |
| Net Invested Capital | $ 352.8 M | |
| Invested Capital | $ 352.8 M | |
| Net Tangible Assets | $ -92.26 M | |
| Net Working Capital | $ 51.2 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.533 | |
| Current Ratio | 1.942 | |
| Current Ratio QoQ | -3.743 % | |
| Current Ratio YoY | 173.09 % | |
| Current Ratio IPRWA | high: 20.133 mean: 2.657 MLAB: 1.942 median: 1.893 low: 0.042 |
|
| Quick Ratio | 1.454 | |
| Quick Ratio QoQ | 0.734 % | |
| Quick Ratio YoY | 173.923 % | |
| Quick Ratio IPRWA | high: 12.347 mean: 1.999 MLAB: 1.454 median: 1.245 low: 0.366 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 13.56 | |
| Cost Of Debt | 1.291 % | |
| Interest Coverage Ratio | 2.514 | |
| Interest Coverage Ratio QoQ | 48.006 % | |
| Interest Coverage Ratio YoY | 1043.066 % | |
| Interest Coverage Ratio IPRWA | high: 60.521 median: 25.964 mean: 20.419 MLAB: 2.514 low: -107.569 |
|
| Operating Cash Flow Ratio | 0.194 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 20.161 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | 4.106 | |
| Dividend Payout Ratio | 0.244 | |
| Dividend Rate | $ 0.16 | |
| Dividend Yield | 0.002 | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 1.045 % | |
| Revenue Growth | 7.226 % | |
| Revenue Growth QoQ | 260.399 % | |
| Revenue Growth YoY | -16.54 % | |
| Revenue Growth IPRWA | high: 54.001 % median: 12.969 % mean: 10.211 % MLAB: 7.226 % low: -28.254 % |
|
| Earnings Growth | 291.111 % | |
| Earnings Growth QoQ | 2279.524 % | |
| Earnings Growth YoY | -319.706 % | |
| Earnings Growth IPRWA | MLAB: 291.111 % high: 100.0 % mean: 9.503 % median: 6.667 % low: -142.105 % |
|
| MARGINS | ||
| Gross Margin | 64.176 % | |
| Gross Margin QoQ | 4.414 % | |
| Gross Margin YoY | 1.445 % | |
| Gross Margin IPRWA | high: 96.557 % median: 64.538 % MLAB: 64.176 % mean: 61.845 % low: -16.207 % |
|
| EBIT Margin | 11.719 % | |
| EBIT Margin QoQ | 46.433 % | |
| EBIT Margin YoY | 1077.789 % | |
| EBIT Margin IPRWA | high: 33.51 % median: 20.883 % mean: 20.561 % MLAB: 11.719 % low: -144.871 % |
|
| Return On Sales (ROS) | 12.245 % | |
| Return On Sales QoQ | 57.431 % | |
| Return On Sales YoY | 1130.653 % | |
| Return On Sales IPRWA | high: 35.479 % median: 21.965 % mean: 21.695 % MLAB: 12.245 % low: -169.778 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 18.0 M | |
| Free Cash Flow Yield | 4.073 % | |
| Free Cash Flow Yield QoQ | 132.477 % | |
| Free Cash Flow Yield YoY | 64.102 % | |
| Free Cash Flow Yield IPRWA | MLAB: 4.073 % high: 3.107 % median: 0.969 % mean: 0.968 % low: -18.554 % |
|
| Free Cash Growth | 152.763 % | |
| Free Cash Growth QoQ | -78.379 % | |
| Free Cash Growth YoY | -62.379 % | |
| Free Cash Growth IPRWA | high: 265.331 % MLAB: 152.763 % mean: 8.256 % median: -0.761 % low: -358.281 % |
|
| Free Cash To Net Income | 4.965 | |
| Cash Flow Margin | 16.195 % | |
| Cash Flow To Earnings | 2.906 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 0.839 % | |
| Return On Assets QoQ | 46.678 % | |
| Return On Assets YoY | -323.138 % | |
| Return On Assets IPRWA | high: 15.87 % mean: 2.007 % median: 1.613 % MLAB: 0.839 % low: -29.663 % |
|
| Return On Capital Employed (ROCE) | 2.006 % | |
| Return On Equity (ROE) | 0.019 | |
| Return On Equity QoQ | 40.159 % | |
| Return On Equity YoY | -280.0 % | |
| Return On Equity IPRWA | high: 0.357 mean: 0.031 median: 0.031 MLAB: 0.019 low: -0.518 |
|
| DuPont ROE | 1.988 % | |
| Return On Invested Capital (ROIC) | 1.708 % | |
| Return On Invested Capital QoQ | 57.13 % | |
| Return On Invested Capital YoY | 153.037 % | |
| Return On Invested Capital IPRWA | high: 6.199 % mean: 2.714 % median: 2.587 % MLAB: 1.708 % low: -19.559 % |
|